Feb 22, 2024 / 04:00PM GMT
Yigal Nochomovitz - Citi - Moderator
Great. Welcome, everyone to the next session of Citi's Virtual Oncology Leadership Summit. I'm Yigal Nochomovitz, I'm one of the biotech analysts here at Citigroup. (Conference Instructions)
So with that, it's my great pleasure to welcome some of the senior leadership from Zymeworks. I have with me Chris Astle, the SVP and CFO of the company; and Paul Moore, the CSO of the company. So thank you both very, very much for joining. It's great to have you here.
So maybe one of you could give a quick overview of the company just in terms of the platform, technologies, the key pipeline, assets. And then from there, we can dig into some of the details in terms of your clinical programs. Thanks.
Chris Astle - Zymeworks Inc. - SVP & CEO
Thank you. We're glad to be here, and I'll kick off and hand over to Paul to talk a little bit more about the platform and some of our pipeline. But yeah, Zymeworks, we are a global biotechnology company with the goal of developing a diverse pipeline of novel multifunctional
Zymeworks Inc at Citi Virtual Oncology Leadership Summit Transcript
Mar 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers